免疫逃逸作为癌症免疫治疗的主要挑战
Immune Evasion as the Main Challenge for Immunotherapy of Cancer.
作者信息
Zagozdzon Radoslaw, Winiarska Magdalena, Firczuk Malgorzata
机构信息
Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59 Street, 02-006 Warsaw, Poland.
Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Street, 02-097 Warsaw, Poland.
出版信息
Cancers (Basel). 2022 Jul 26;14(15):3622. doi: 10.3390/cancers14153622.
Abstract
Immune evasion is currently considered one of the most prominent hallmarks of cancer [...].
摘要
免疫逃逸目前被认为是癌症最显著的特征之一[……]。
相似文献
1
Immune Evasion as the Main Challenge for Immunotherapy of Cancer.免疫逃逸作为癌症免疫治疗的主要挑战
Cancers (Basel). 2022 Jul 26;14(15):3622. doi: 10.3390/cancers14153622.
2
Interplay between the DNA Damage Response and Immunotherapy Response in Cancer.癌症中 DNA 损伤反应与免疫治疗反应的相互作用。
Int J Mol Sci. 2022 Nov 1;23(21):13356. doi: 10.3390/ijms232113356.
3
Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.将肿瘤糖酵解与癌症中的免疫逃逸联系起来：新出现的概念和治疗机会。
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):212-220. doi: 10.1016/j.bbcan.2017.04.002. Epub 2017 Apr 8.
4
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.人类前列腺癌的免疫景观：免疫逃逸机制和个性化免疫治疗的生物标志物。
BMC Cancer. 2020 Jun 18;20(1):572. doi: 10.1186/s12885-020-07058-y.
5
Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy.淋巴瘤免疫逃逸的两种策略：隐藏或防御——对免疫治疗的潜在影响。
Haematologica. 2018 Aug;103(8):1256-1268. doi: 10.3324/haematol.2017.184192. Epub 2018 Jul 13.
6
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas.内在免疫逃逸模式预测低级别脑胶质瘤替莫唑胺敏感性和免疫治疗反应。
BMC Cancer. 2022 Sep 12;22(1):973. doi: 10.1186/s12885-022-09984-5.
7
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.基于免疫逃逸机制对乳腺癌患者进行亚组分类，揭示转化生长因子-β和诱饵受体 3 的高参与度。
PLoS One. 2018 Dec 4;13(12):e0207799. doi: 10.1371/journal.pone.0207799. eCollection 2018.
8
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment.食管鳞状细胞癌中的免疫逃逸：从肿瘤微环境的角度来看
Front Oncol. 2023 Jan 9;12:1096717. doi: 10.3389/fonc.2022.1096717. eCollection 2022.
9
Cancer Immunology and Immunotherapy.癌症免疫学与免疫疗法
Anticancer Res. 2016 Nov;36(11):5593-5606. doi: 10.21873/anticanres.11144.
10
Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy.基于纳米技术的小干扰RNA递送系统用于克服癌症免疫治疗中的肿瘤免疫逃逸
Pharmaceutics. 2022 Jun 25;14(7):1344. doi: 10.3390/pharmaceutics14071344.
引用本文的文献
1
Cancer-associated fibroblast-mediated immune evasion: molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment.癌症相关成纤维细胞介导的免疫逃逸：肿瘤微环境中基质 - 免疫相互作用的分子机制
Front Immunol. 2025 Aug 26;16:1617662. doi: 10.3389/fimmu.2025.1617662. eCollection 2025.
2
The role of histone methyltransferases in therapeutic resistance of NSCLC.组蛋白甲基转移酶在非小细胞肺癌治疗耐药中的作用。
Epigenetics. 2025 Dec;20(1):2536786. doi: 10.1080/15592294.2025.2536786. Epub 2025 Jul 23.
3
Editorial: Regulation of tumor-immune microenvironment by non-coding RNAs.社论：非编码RNA对肿瘤免疫微环境的调控
Front Immunol. 2024 Jan 16;15:1362881. doi: 10.3389/fimmu.2024.1362881. eCollection 2024.
4
Spreading Senescent Cells' Burden and Emerging Therapeutic Targets for Frailty.衰老细胞负担的传播和脆弱性的新兴治疗靶点。
Cells. 2023 Sep 15;12(18):2287. doi: 10.3390/cells12182287.
5
Human β-Defensins in Diagnosis of Head and Neck Cancers.人 β-防御素在头颈部癌症诊断中的应用。
Cells. 2023 Mar 7;12(6):830. doi: 10.3390/cells12060830.
6
New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination.早期 NSCLC 管理的新方法：PARP 抑制剂和免疫疗法联合的潜在应用。
Int J Mol Sci. 2023 Feb 17;24(4):4044. doi: 10.3390/ijms24044044.
7
The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy.T细胞在头颈部鳞状细胞癌中的作用：从免疫到免疫治疗。
Front Oncol. 2022 Oct 20;12:1021609. doi: 10.3389/fonc.2022.1021609. eCollection 2022.
本文引用的文献
1
Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion.3D生物打印在肿瘤免疫逃逸建模中的应用前景
Cancers (Basel). 2022 Jun 26;14(13):3126. doi: 10.3390/cancers14133126.
2
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.乳腺癌的免疫格局：克服免疫治疗耐药性的策略
Cancers (Basel). 2021 Nov 29;13(23):6012. doi: 10.3390/cancers13236012.
3
Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies.重塑肿瘤髓系微环境以增强抗肿瘤抗体免疫疗法
Cancers (Basel). 2021 Sep 29;13(19):4904. doi: 10.3390/cancers13194904.
4
Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis.中性粒细胞胞外诱捕网（NETs）在癌症侵袭、逃逸和转移中的作用
Cancers (Basel). 2021 Sep 6;13(17):4495. doi: 10.3390/cancers13174495.
5
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer.癌基因与氧化还原信号在癌症中对程序性死亡受体1配体（PD-L1）调控的作用
Cancers (Basel). 2021 Sep 2;13(17):4426. doi: 10.3390/cancers13174426.
6
PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4 T Cells.PD-L1过表达、SWI/SNF复合物失调以及深刻的转录组变化是持续活化的CD4 T细胞癌症依赖性耗竭的特征。
Cancers (Basel). 2021 Aug 18;13(16):4148. doi: 10.3390/cancers13164148.
7
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.IOBR：多组学免疫肿瘤生物学研究解码肿瘤微环境和特征。
Front Immunol. 2021 Jul 2;12:687975. doi: 10.3389/fimmu.2021.687975. eCollection 2021.
8
Applications of Single-Cell Omics in Tumor Immunology.单细胞组学在肿瘤免疫学中的应用。
Front Immunol. 2021 Jun 9;12:697412. doi: 10.3389/fimmu.2021.697412. eCollection 2021.
9
3D Bioprinting of Model Tissues That Mimic the Tumor Microenvironment.模拟肿瘤微环境的模型组织的3D生物打印
Micromachines (Basel). 2021 May 9;12(5):535. doi: 10.3390/mi12050535.
10
The Role of Macrophages in Cancer Development and Therapy.巨噬细胞在癌症发展与治疗中的作用
Cancers (Basel). 2021 Apr 18;13(8):1946. doi: 10.3390/cancers13081946.
Zotero 插件